Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial

[1] Landmesser U(2004)Endothelial function: a critical determinant in atherosclerosis? Circulation 109 II27-II33

[2] Hornig B(2006)Vascular endothelium and atherosclerosis Handb Exp Pharmacol 176 285-306

[3] Drexler H(2001)Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 1879-1887

[4] Libby P(2006)5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study Lancet 368 998-1004

[5] Aikawa M(2007)Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 1503-1516

[6] Jain MK(2009)Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE trial) Am J Cardiol 104 1-4

[7] Cannon CP(2009)A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2503-2515

[8] Weintraub WS(2009)Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease Am J Cardiol 104 1647-1653

[9] Demopoulos LA(2009)Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (clinical outcomes utilizing revascularization and aggressive drug evaluation) trial J Am Coll Cardiol 54 1303-1308

[10] Vicari R(2008)Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 677-687

[1] Landmesser U(2004)Endothelial function: a critical determinant in atherosclerosis? Circulation 109 II27-II33

[2] Hornig B(2006)Vascular endothelium and atherosclerosis Handb Exp Pharmacol 176 285-306

[3] Drexler H(2001)Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 1879-1887

[4] Libby P(2006)5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study Lancet 368 998-1004

[5] Aikawa M(2007)Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 1503-1516

[6] Jain MK(2009)Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE trial) Am J Cardiol 104 1-4

[7] Cannon CP(2009)A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2503-2515

[8] Weintraub WS(2009)Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease Am J Cardiol 104 1647-1653

[9] Demopoulos LA(2009)Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (clinical outcomes utilizing revascularization and aggressive drug evaluation) trial J Am Coll Cardiol 54 1303-1308

[10] Vicari R(2008)Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 677-687